References
- Alvord E. C. The pathology of Parkinsonism: Part II. An interpretation with special reference to other changes in the aging brain. Recent advances in Parkinson's disease, F. H. McDowell, C. H. Markham. Davis, Philadelphia 1971
- Barbeau A. Experience clinique avec le tolbutamide dans la maladie de Parkinson. Union Medicate Cannada 1961; 90: 147–151
- Barbeau A., Pourcher E. Genetics of early onset Parkinson's disease. Current concepts of Parkinson disease and related disorders, M. D. Yahr. Excerpta Medica, Amsterdam 1983
- Benson D. F. Parkinsonian dementia: cortical or subcortical. Advances in neurology, R. G. Hassler, J. F. Christ. Raven Press, New York 1984; vol. 40: 235–240
- Boiler F., Mizutani T., Roessmann U. Parkinson's disease, dementia and Alzheimer's disease: Clinico-pathological correlations. Annals of Neurology 1980; 7: 329–335
- Hakim A. M., Mathieson G. Dementia in Parkinson disease: A neuropathologic study. Neurology 1979; 29: 1209–1214
- Hirano A., Zimmerman H. M. Alzheimer's neurofibrillary changes. Archives of Neurology 1962; 7: 227–243
- Langston J. W., Forno L. S. The hypothalamus in Parkinson disease. Annals of Neurology 1978; 3: 129–133
- Lieberman A., Dziatolowski M., Kupersmith M., Serby M., Goodgold A., Korien J., Goldstein M. Dementia in Parkinson disease. Annals of Neurology 1979; 6: 355–359
- Lipman I. J., Boykin M. E., Flora R. E. Glucose intolerance in Parkinson's disease. Journal of Chronic Diseases 1974; 27: 573–579
- Mortimer J. A., Pirozzolo F. J., Hansch E. C. Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology 1982; 32: 133–137
- Sandyk R. The effects of dopamine hydrochloride on insulin action in isolated rat adipocytes. M.Sc. Dissertation, University of the Witwatersrand, JohannesburgSouth Africa 1984
- Sandyk R., Iacono R. P., Bamford C. R. The hypothalamus in Parkinson disease. Italian Journal of Neurological Sciences 1987; 8: 227–234
- Sandyk R., Awerbuch G. I., Iacono R. P. Diabetes mellitus as a risk factor for drug-induced Parkinsonism in schizophrenia. International Journal of Neuroscience 1991; 61: 149–188
- Szabo O., Szabo A. J. Effects of autonomic neurotransmitter and inhibitor drugs on the insulin sensitive CNS glucoregulatory center. Diabetes 1974; 23: 342
- Szabo A. J., Szabo O. Influence of the insulin sensitive CNS regulator receptor on hepatic glucose metabolism. Journal of Physiology 1975; 253: 121–133
- Schwab R. S. Progression and prognosis in Parkinson's disease. Journal of Nervous and Mental Disease 1960; 130: 556–566
- Van Woert M. H., Mueller P. S. Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa. Clinical Pharmacology & Therapeutics 1971; 12: 360–367